Medical Technology Start-ups Get a Critical Boost Via “America’s Seed Fund”
The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs offer a lifeline to small medical technology companies that otherwise would not be able to secure the initial funding necessary for expensive research and development.
The programs support scientific development and product innovation benefiting patients in need and the public at large. They also spur growth in the U.S. and local economies by helping small businesses implement their groundbreaking ideas.
Start-up medical technology makers are among the innovators nationwide who compete for SBIR and STTR program grants. Some of today’s biggest medical technology companies started as yesterday’s start-ups. They might not have succeeded in developing their life-saving, life-enhancing products without critical early funding from what’s called “America’s Seed Fund.”
The legislative authorization for these initiatives is set to expire September 30, 2022. Congress has long given them strong bipartisan support.
Read more about how the Small Business Innovation Research and Small Business Technology Transfer programs help bring innovative medical technology to life.
Help Keep the SBIR Program Alive
Contact your legislators to help make sure Congress renews the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.